Shared decision-making is an approach where physicians and patients work together to
determine a personalized treatment course. Such an approach is integral to patient-centered …

Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a type 2 pattern of
inflammation resulting in the production of some cytokines. Dupilumab radically changes the …

Introduction Chronic sinusitis with nasal polyposis (CRSwNP) is a common heterogeneous
disease that mainly manifests as chronic inflammation of the sinus mucosa. The effect of …

Mepolizumab is primarily used in the treatment of asthma, eosinophilic granulomatosis with
polyangiitis, eosinophilia syndrome, and chronic rhinitis with nasal polyps. The information …

Objectives Ocular surface reactions (OSR) have been associated with dupilumab for atopic
dermatitis (AD) treatment. However, the association of dupilumab‐associated OSR (DA …

Introduction Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent inflammatory
condition with heterogenous underlying endotypes, the most common being type 2 …

Purpose Biologics represent a new therapeutic strategy for severe and recurrent chronic
rhinosinusitis with nasal polyps (CRSwNP). Usually, their actual therapeutic effectiveness is …

Purpose of review This review explores the comprehensive management and treatment
strategies for pediatric chronic rhinosinusitis with nasal polyps (CRSwNP). It addresses …

Purpose: Nasal polyps (NPs), usually occurring together with chronic rhinosinusitis (CRS),
are benign masses of mucosal origin arising from inflammation. The transmembrane protein …